A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder

por Liebowitz, Michael R, Tourian, Karen A, Hwang, Eunhee, Mele, Linda
Publicado 2013

Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumati...

por Machado, Daniel A., Guzman, Renato, Xavier, Ricardo M., Simon, Jesus A., Mele, Linda, Shen, Qi, Pedersen, Ronald, Kotak, Sameer, Vlahos, Bonnie
Publicado 2016

Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study

por Panés, Julián, D’Haens, Geert R., Higgins, Peter D. R., Mele, Linda, Moscariello, Michele, Chan, Gary, Wang, Wenjin, Niezychowski, Wojciech, Su, Chinyu, Maller, Eric
Publicado 2019

The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a...

por Moots, Robert J., Xavier, Ricardo M., Mok, Chi Chiu, Rahman, Mahboob U., Tsai, Wen-Chan, Al-Maini, Mustafa H., Pavelka, Karel, Mahgoub, Ehab, Kotak, Sameer, Korth-Bradley, Joan, Pedersen, Ron, Mele, Linda, Shen, Qi, Vlahos, Bonnie
Publicado 2017

Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Res...

por Moots, Robert J., Xavier, Ricardo M., Mok, Chi Chiu, Rahman, Mahboob U., Tsai, Wen-Chan, Al-Maini, Mustafa H., Pavelka, Karel, Mahgoub, Ehab, Kotak, Sameer, Korth-Bradley, Joan, Pedersen, Ron, Mele, Linda, Shen, Qi, Vlahos, Bonnie
Publicado 2017